Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | H60 - Navigating the Future of Neurology: Unveiling Natural Language Processing's (NLP's) Impact and Addressing Interoperability Challenges (Practice and Policy Hub)

Sunday 04/14/24
01:30 PM - 02:30 PM MDT Add To Calendar
Colorado Convention Center | Lobby F
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Practice and Policy)
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN, Allan Ding Wu, MD, FAAN, Shawn N. Murphy, MD
Practice, Policy, and Ethics
Participants should better understand the current state of NLP technology in neurology and its impact on patient care, identify best practices for implementing NLP systems in neurology settings, recognize the interoperability challenges in integrating NLP with existing health care systems, develop strategies to overcome barriers to NLP implementation in neurology practice, and learn to apply NLP tools effectively in clinical practice for enhanced patient outcomes.
1.00 CME credit
Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Advanced
Diversity, Equity, and Inclusion
Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Business Administrator
Case-based, Didactic, Audience Participation, Other

Program Materials Program Evaluations

Event Timeline
01:30 PM - 01:40 PM MDT Speaker Introduction and Overview of NLP in Neurology
Allan Ding Wu, MD, FAAN
01:40 PM - 01:50 PM MDT Discussion Discussing Current Practices and Identifying Gaps
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN
01:50 PM - 02:00 PM MDT Speaker Best Practices for NLP Integration in Neurology
Shawn N. Murphy, MD
02:00 PM - 02:10 PM MDT Speaker Overcoming Interoperability Challenges
Shawn N. Murphy, MD
02:10 PM - 02:20 PM MDT Q&A Interactive Session: Demonstrations and Practical Applications of NLP
Courtney Reamer, MD
02:20 PM - 02:30 PM MDT Closing Remarks Q&A Session, Concluding Remarks
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN
Faculty Disclosures
Shawn N. Murphy, MD Dr. Murphy has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Kenner Family Research Fund. Dr. Murphy has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with i2b2-transmart foundation.
Allan Ding Wu, MD, FAAN An immediate family member of Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. An immediate family member of Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocodex. The institution of Dr. Wu has received research support from Michael J Fox Foundation. The institution of an immediate family member of Dr. Wu has received research support from Amzell. The institution of Dr. Wu has received research support from Centers for Disease Control. Dr. Wu has a non-compensated relationship as a Neuroscience Steering Board with Epic that is relevant to AAN interests or activities.
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .
Courtney Reamer, MD Courtney Reamer, MD has nothing to disclose.